导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 6.05% | 357/1050 |
| 近一周 | -2.76% | 716/1104 |
| 近一月 | -1.80% | 200/1102 |
| 近一季 | -1.88% | 322/1092 |
| 近半年 | -8.64% | 723/1070 |
| 近一年 | 16.27% | 278/1018 |
| 近两年 | 71.85% | 345/926 |
| 近三年 | 90.58% | 103/834 |
| 成立以来 | 564.20% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
12.11% 30/1070 |
-4.55% 778/1101 |
- - |
- - |
| 2025 | 33.13% 424/1065 |
2.12% 641/1014 |
1.39% 560/1038 |
23.96% 481/1050 |
3.73% 207/1065 |
| 2024 | 34.31% 12/1011 |
10.97% 21/960 |
5.77% 77/983 |
20.63% 54/991 |
-5.14% 677/1011 |
| 2023 | -2.05% 137/952 |
4.87% 338/880 |
-7.62% 677/895 |
0.60% 71/915 |
0.50% 107/952 |
| 2022 | -12.95% 134/867 |
-12.82% 170/773 |
7.64% 366/806 |
-11.39% 335/845 |
4.68% 223/867 |
| 2021 | -11.94% 499/740 |
-0.59% 175/580 |
0.45% 540/659 |
-7.00% 411/704 |
-5.18% 594/740 |
| 2020 | 101.99% 27/554 |
4.64% 78/419 |
32.97% 90/466 |
27.79% 13/517 |
13.59% 236/554 |
| 2019 | 64.59% 59/410 |
34.87% 148/1149 |
-2.20% 534/1231 |
11.77% 84/390 |
11.64% 118/410 |
| 2018 | -24.19% 133/349 |
- - |
- - |
- - |
-8.88% 201/1080 |
| 2017 | 33.78% 26/285 |
- - |
- - |
- - |
- - |
| 2016 | -22.50% 127/205 |
- - |
- - |
- - |
- - |
| 2015 | 44.98% 32/151 |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票C | 0.8165 | 61.04% |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商医药健康产业股票 | 2.6450 | 53.78% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 嘉实医疗保健股票 | 2.6190 | 42.34% |
| 前海开源公共卫生股票C | 0.4647 | 42.24% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 广发医药精选股票C | 1.3103 | 40.86% |
| 交银医药创新股票C | 3.0948 | 37.26% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 招商行业精选股票基金 VS. 东吴新产业精选股票A(580008) |